DRL
Location
Vlaams Brabant
Founded
1980-09-05
Website
Risk Signals
105 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Furniture, Catalog and Mail-Order Houses), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about DRL
Live alerts from global media, monitored by Business Radar
2025-05-16 (economictimes.com)
DRL gears up for biosimilar push, consumer health growth post record FY25 -
Dr Reddys stock rose 5.5% in six sessions post-Q4 results, outperforming the BSE Healthcare index. Strong revenue growth, biosimilar launches, and semaglutide portfolio support long-term prospects despite Revlimid taper and reduced target prices by analysts.
Read more
(indiatimes.com)
DRL Q1 net up 45% at Rs 663 cr; Israeli is new CEO from Aug 1 - Times of India
India Business News: Hyderabad: Despite price erosion due to increased competition in the US and Europe, and lower sales from PSAI (Pharmaceuticals Services and Active Ing.
Read more